Orthofix Medical (OFIX) Osake Kurssi
Orthofix Medical Kurssi
Liikevaihto on kasvanut 4,4 % vuodessa viimeisten 19 vuoden aikana 822,31 M USD:een. Osakekohtainen tulos on laskenut 11,6 % vuodessa viimeisten 13 vuoden aikana. Orthofix Medicaln nettomarginaali on nyt −11,2 %, laskenut −8,3 %:sta muutama vuosi sitten. Analyytikoiden mediaanitavoitehinta on 13,00 USD, eli yli nykyhintaa 32,9 %. 11 analyytikosta 8 suosittaa ostoa — kokonaiskonsensus on Osta.
Orthofix Medical osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Orthofix Medical liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Orthofix Medical -osakkeesta
The business model of Orthofix Medical Inc. revolves around providing innovative medical solutions for the orthopedic and spine markets. The company focuses on developing, manufacturing, and marketing advanced medical devices and non-invasive orthopedic solutions. Orthofix Medical Inc. aims to improve patients' quality of life by offering technologically advanced products and therapies that aid in the treatment of various musculoskeletal conditions. They strive to deliver exceptional patient outcomes by combining industry-leading technology, clinical expertise, and evidence-based medicine. Orthofix Medical Inc. is committed to driving innovation, advancing patient care, and solidifying its position as a leading player in the orthopedic medical device industry.
Orthofix Medical Inc is primarily active in the healthcare industry, specifically focusing on orthopedic medical devices. With a strong commitment to improving patient mobility and quality of life, Orthofix offers a wide range of innovative products and solutions in spine fixation, bone growth stimulation, and biologics. Their expertise in orthopedics allows them to serve various healthcare professionals, including surgeons, physicians, and hospitals worldwide. Orthofix Medical Inc's extensive experience and dedication to advancing orthopedic care make them a key player in the industry, providing valuable solutions for patients and healthcare providers alike.
The main competitors of Orthofix Medical Inc in the market include Stryker Corporation, Zimmer Biomet Holdings Inc, DJO Global, Inc, and Medtronic PLC.
Orthofix Medical Inc. is a renowned medical device company with a rich history and background. Established in 1987, Orthofix has been dedicated to advancing orthopedic solutions and improving patient outcomes. With its headquarters in Lewisville, Texas, the company operates through various business segments, including Spinal Implants, Biologics, and External Fixation. Orthofix is committed to delivering innovative and high-quality products that help patients regain mobility and improve their quality of life. The company has a global presence and serves healthcare providers and patients worldwide. With its strong focus on research and development, Orthofix continues to shape the future of orthopedic care.
Orthofix Medical Inc has achieved significant milestones throughout its history. One notable achievement is the company's development of innovative medical devices and solutions for orthopedic and spine conditions. Additionally, Orthofix Medical Inc has successfully expanded its global presence, reaching healthcare professionals and patients worldwide. The company has also demonstrated its commitment to research and development, continuously introducing advanced technologies and treatments in the orthopedic field. Moreover, Orthofix Medical Inc has made strategic acquisitions and partnerships, further enhancing its product portfolio and market position. These milestones showcase Orthofix Medical Inc's dedication to improving patient outcomes and advancing the field of orthopedics.
Orthofix Medical Inc is primarily present in countries and regions worldwide. The company operates in North America, Europe, Asia-Pacific, Latin America, and the Middle East. With a global presence, Orthofix Medical Inc has established a strong market position and serves patients and healthcare professionals in multiple countries and regions.
Orthofix Medical Inc represents the values of innovation, integrity, and patient-centricity. With a corporate philosophy deeply rooted in improving patients' lives, Orthofix Medical Inc is committed to developing and providing innovative orthopedic solutions. The company strives to maintain the highest standards of integrity and ethical conduct in all its operations. Through its cutting-edge technologies and dedication to research and development, Orthofix Medical Inc aims to deliver advanced medical devices and therapies that meet the unique needs of patients worldwide.
Analyytikot asettavat tällä hetkellä Orthofix Medical-osakkeelle keskimääräisen tavoitehinnan 13,40 USD (mediaani: 13,00 USD), mikä merkitsee +37,0 % viimeisimpään hintaan verrattuna. Konsensus perustuu 11 analyytikkoarvioon.
11 analyytikkoa arvioi tällä hetkellä Orthofix Medical-osaketta: 8 suosittaa ostoa, 3 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Orthofix Medical-yhtiöltä 851,20 M USD liikevaihtoa ja −1,16 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Orthofix Medical-osake noteerataan hintaan 8,74 EUR (9,78 USD).
Orthofix Medical-osake (OFIX) on listattuna 2 pörssissä, muun muassa: NASDAQ (OFIX), Frankfurt (OM2.F).
Orthofix Medical Inc is a globally leading medical technology company specializing in innovative orthopedic products in the global market. The company is headquartered in Lewisville, Texas, and has offices in over 50 countries. Orthofix Medical Inc specializes in providing high-quality solutions for complex orthopedic problems. Orthofix Medical consists of four main business areas: Extremities, Spine, Biologics, and International Operations. The Extremities division focuses on manufacturing products and instruments that target wrist and elbow surgery. The Spine division produces solutions for a variety of back problems, including herniated discs, scoliosis, and other complications. Biologics produces biological products that promote natural body regeneration and are suitable for use in orthopedic surgery. The International division supports the businesses that Orthofix Medical Inc operates in Europe, Asia, Latin America, and other regions of the world. Orthofix Medical Inc offers a wide range of products, including orthopedic implants, surgical instruments, bio-implants, and biological allografts. The company is a leader in developing solutions for bone regeneration and arthroscopic surgery. Among Orthofix Medical Inc's most well-known products are the M6-C core replacement, Octopus leg holder, and Trinity-ELITE bone replacement. In addition to its core competency of manufacturing high-quality orthopedic products, Orthofix Medical also offers innovative services. Orthofix Medical Inc provides its customers with training, certification programs, technical support, and consultation. Supporting physicians and clinics is an important part of Orthofix Medical's business philosophy. The business strategy of Orthofix Medical Inc aims to promote company growth through organic expansion and strategic acquisitions of companies operating in the fields of orthopedics, biology, and surgery. The company continuously invests in research and development to develop innovative solutions to address complex orthopedic challenges. Orthofix Medical Inc is also committed to high social and environmentally-friendly standards. The company follows a proactive environmental policy and strives to utilize resources efficiently and reduce waste. Orthofix Medical's corporate responsibility is also evident in its support of nonprofit organizations and its employees' involvement in supporting social projects. Overall, Orthofix Medical Inc has taken a leading role in the orthopedic industry by offering innovative products and services that help clinics and physicians address complex orthopedic problems. The company is committed to promoting its growth through continuous innovation and a proactive commitment to social and environmental responsibility.
odotettu liikevaihto Orthofix Medical on 851,20 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Orthofix Medical on −46,53 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Orthofix Medical:n hinta-voitto-suhde (P/E) on tällä hetkellä −8,41. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Orthofix Medical-osakkeen arvostusta.
Orthofix Medical:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,46. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Orthofix Medical-osakkeen arvostuskennuslukuna.
Orthofix Medical:n Eulpool-laatuscore on 3/10.
Orthofix Medical:n ISIN on US68752M1080. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Orthofix Medical:n WKN on A2NB0X. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Orthofix Medical:n ticker on OFIX. Tämä pörssinoteeraus käytetään Orthofix Medical-osakkeiden kauppaan pörssissä.
Orthofix Medical osake
Orthofix Medical vertaisryhmä
Orthofix Medical Ticker
Orthofix Medical FIGI
Kaikki tunnusluvut ja syvällinen analyysi Orthofix Medical:sta
Meidän osakeanalyysimme Orthofix Medical-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Orthofix Medical:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: